This growing interest, the functional role of TRIM21 during viral infection remains incompletely understood

The gap

Evidence profile

Sourced from the limitations section and discussion and future work of the source papers, classified as general, drawn from work published between 2024 and 2026, spanning 2 journals. Those papers have been cited 17 times in total.

Supporting evidence — 3 representative gaps

• TRIM32 inhibits Venezuelan equine encephalitis virus infection by targeting a late step in viral entry (2024) · PLoS Pathogens · cited 10× · doi

  Additional TRIM32 gene silencing studies in primary cells will help confirm our studies in immortalized cells that TRIM32 functions as a cell intrinsic restriction factor. TRIM32 does not appear to be an ISG, emphasizing the need for additional studies to understand how TRIM32 expression is regulated. Our mechanistic studies did not include assays to directly investigate endosomal fusion, and R18-labeled virus could assist in further narrowing the proposed late entry mechanism. While mutagenesis indicates that the E3 ligase activity of TRIM32 is important for its effects on VEEV, additional studies are needed to identify whether a viral or host factor is ubiquitinated by TRIM32, and what the consequence of this modification is.

  generallimitations section
  Keywords: additional trim32 gene silencing studies primary cells help
• TRIM21 is a molecular rheostat for influenza A virus replication (2026) · doi

  Despite this growing interest, the functional role of TRIM21 during viral infection remains incompletely understood, with seemingly conflicting findings describing it as either antiviral or proviral63. This framework provides a mechanistic explanation for previously conflicting reports of TRIM21 function by suggesting that divergent phenotypes arise from differences in cellular context, infection stage, or TRIM21 abundance.

  generaldiscussionevidence 5/5
  Keywords: trim infection conflicting despite growing interest functional role viral remains incompletely understood seemingly describing either
• Emerging Roles of TRIM56 in Antiviral Innate Immunity (2025) · Viruses · cited 7× · doi

  It has become increasingly clear that TRIM56 is an important, multifunctional player in host innate immune responses fending off viral infections. Whereas the last ~one and a half decades have witnessed a number of exciting discoveries of the various new roles that TRIM56 plays in antiviral immune signaling and as a direct virus restriction factor, much remains to be learned about the detailed, regulatory and effector mechanisms by which TRIM56 operates in these processes. Precisely how TRIM56 is activated and enlisted and acts to combat a broad range of viruses remains murky. The substrates for the E3 ligase of TRIM56 that underlie the “direct” antiviral effects are, by and large, elusive. The discovery of TRIM56’s direct viral RNA binding ability provides new insights into its antiviral mechanism against some RNA viruses, and further studies are necessary to determine whether RNA binding by the NHL-like domain of TRIM56 modulates its E3 ligase activity. To fully understand the functions and regulation of TRIM56, it will be helpful to study the different isoforms of TRIM56. Specifically, whether the two shorter isoforms exhibit tissue- and/or cell-type-specific distribution and how their expression and activity are regulated following various viral and/or immune stimuli. Also, clarifications on the contradictory roles reported for the TRIM56 ubiquitin ligase in cGAS-STING signaling are much needed, as is the exact biology underpinning the non-canonical, E3 ligase-independent involvement of TRIM56 in the TLR3-TRIF pathway. Last but not least, investigating the contributions of TRIM56 to regulating viral fitness and immune responses in appropriate animal models will help establish the biological relevance of many of the findings suggested in cell culture models and whether specific aspects of TRIM56-virus interplay hold the potential for therapeutic targeting. Funding: The TRIM56-related work in the Li laboratory was supported in part by National Institutes of Health grants AI101526, AI137812, and AI069285 to K.L. The funder had no role in study design, data collection and interpretation, and the decision to submit the work for publication or preparation of the manuscript. Acknowledgments: The authors thank the anonymous reviewers for their valuable feedback. Conflicts of Interest: The authors declare no conflict of interest.

  generalfuture workevidence 5/5
  Keywords: trim immune viral ligase antiviral direct whether responses last various roles signaling virus remains viruses

Questions about this gap